|
IPR002223
|
Proteinase inhibitor I2, Kunitz metazoa
|
17 (2.53 %)
|
|
IPR013783
|
Immunoglobulin-like fold
|
15 (2.23 %)
|
|
IPR020901
|
Proteinase inhibitor I2, Kunitz, conserved site
|
15 (2.23 %)
|
|
IPR013128
|
Peptidase C1A
|
10 (1.49 %)
|
|
IPR017853
|
Glycoside hydrolase, superfamily
|
10 (1.49 %)
|
|
IPR000668
|
Peptidase C1A, papain C-terminal
|
10 (1.49 %)
|
|
IPR025660
|
Cysteine peptidase, histidine active site
|
10 (1.49 %)
|
|
IPR007110
|
Immunoglobulin-like domain
|
10 (1.49 %)
|
|
IPR000169
|
Cysteine peptidase, cysteine active site
|
10 (1.49 %)
|
|
IPR003599
|
Immunoglobulin subtype
|
9 (1.34 %)
|
|
IPR008860
|
Taeniid antigen
|
9 (1.34 %)
|
|
IPR014044
|
Cysteine-rich secretory protein family (CAP)
|
9 (1.34 %)
|
|
IPR013032
|
EGF-like, conserved site
|
9 (1.34 %)
|
|
IPR025661
|
Cysteine peptidase, asparagine active site
|
9 (1.34 %)
|
|
IPR000742
|
Epidermal growth factor-like domain
|
9 (1.34 %)
|
|
IPR013201
|
Proteinase inhibitor I29, cathepsin propeptide
|
8 (1.19 %)
|
|
IPR009057
|
Homeodomain-like
|
8 (1.19 %)
|
|
IPR013098
|
Immunoglobulin I-set
|
7 (1.04 %)
|
|
IPR001356
|
Homeobox domain
|
6 (0.89 %)
|
|
IPR007087
|
Zinc finger, C2H2
|
6 (0.89 %)
|
